| __timestamp | Arrowhead Pharmaceuticals, Inc. | Madrigal Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 15746000 |
| Thursday, January 1, 2015 | 34718089 | 13392000 |
| Friday, January 1, 2016 | 40998209 | 9290000 |
| Sunday, January 1, 2017 | 32022880 | 7672000 |
| Monday, January 1, 2018 | 19110051 | 15293000 |
| Tuesday, January 1, 2019 | 26556257 | 22648000 |
| Wednesday, January 1, 2020 | 52275890 | 21864000 |
| Friday, January 1, 2021 | 80981000 | 37318000 |
| Saturday, January 1, 2022 | 124431000 | 48130000 |
| Sunday, January 1, 2023 | 90932000 | 108146000 |
| Monday, January 1, 2024 | 98761000 |
Unleashing the power of data
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. This analysis compares the SG&A trends of Madrigal Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc. from 2014 to 2023.
Arrowhead Pharmaceuticals has seen a significant increase in SG&A expenses, peaking in 2022 with a 410% rise from 2014. This surge reflects their aggressive expansion and investment in research and development. Conversely, Madrigal Pharmaceuticals experienced a more modest increase, with a notable spike in 2023, marking a 587% rise from their 2014 figures.
Interestingly, 2023 saw Madrigal surpass Arrowhead in SG&A expenses, indicating a strategic shift or increased operational costs. These trends highlight the dynamic nature of the pharmaceutical industry, where strategic financial management can be a key differentiator in achieving long-term success.
Sanofi and Arrowhead Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: argenx SE vs Madrigal Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Madrigal Pharmaceuticals, Inc.
Comparing SG&A Expenses: Madrigal Pharmaceuticals, Inc. vs Opthea Limited Trends and Insights
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Viking Therapeutics, Inc.
Madrigal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Madrigal Pharmaceuticals, Inc. or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
Rhythm Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and Arrowhead Pharmaceuticals, Inc.
Comparing SG&A Expenses: Bausch Health Companies Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Selling, General, and Administrative Costs: Amicus Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.